Effects of administration of oxytocin in association with gonadotropin-releasing hormone on luteinizing hormone levels in rats in vivo.
Gonadotropin-releasing hormone (GnRH) and oxytocin both stimulate the secretion of luteinizing hormone (LH), although with different characteristics. Therefore, interaction between oxytocin and GnRH in the control of LH may be postulated. We developed models for investigating whether oxytocin can modulate GnRH action on LH in vivo. Pentobarbitone is known to pharmacologically isolate the pituitary from hypothalamic GnRH. We found that after pentobarbitone anesthesia of female rats at proestrus, oxytocin caused a synergistically enhanced LH response to administered GnRH (p < 0.04). In a second series of experiments, female proestrous rats were anesthetized with althesin. This anesthetic allows transport of endogenous GnRH from the hypothalamus to the pituitary. In control animals, which received no exogenous hormone, there was a surge in the mean LH concentration on the evening of proestrus, indicating the presence of endogenous GnRH activity. Thus, the novel model enables detection of interactions of administered hormones with endogenous GnRH. Administration of GnRH plus oxytocin in the afternoon of proestrus caused a reduction (p < 0.01) in the mean level of LH observed in the evening. The reduction was larger than if GnRH alone was administered. Following althesin anesthesia, rats sometimes had low LH levels on the afternoon of proestrus. There was a statistically significant difference between the number of rats that received oxytocin plus GnRH and had low LH levels and the number with low LH levels in the control group (p < 0.02). Neither of the hormones administered alone had a significant effect. Thus, it appears that oxytocin accentuated the effect of GnRH in reducing LH concentrations in althesin-anesthetized rats.(ABSTRACT TRUNCATED AT 250 WORDS)
Evans
J J
JJ
University Department of Obstetrics and Gynaecology, Christchurch School of Medicine, New Zealand.
Tulloch
S
S
D000530:Alfaxalone Alfadolone Mixture / Q000494:pharmacology; D000818:Animals; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000187:drug effects / Q000494:pharmacology* / Q000502:physiology; D007031:Hypothalamus / Q000737:chemistry / Q000187:drug effects; D007986:Luteinizing Hormone / Q000097:blood*; D010121:Oxytocin / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D010903:Pituitary Gland, Anterior / Q000737:chemistry / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
D007987:Gonadotropin-Releasing Hormone; D010121:Oxytocin; D000530:Alfaxalone Alfadolone Mixture; D007986:Luteinizing Hormone; D010424:Pentobarbital